OBJECTIVE: Telomere shortening has been observed in many human diseases, including atherosclerosis, cancer, aging syndromes, Alzheimer disease and vascular dementia. The present study aimed to investigate the mean telomere lengths of patients with schizophrenia. METHODS: We analyzed the lengths of telomeric DNA, comparing 2 groups of patients with schizophrenia (34 good responders and 34 poor responders). A control group of 76 healthy volunteers was also included. Blood samples were obtained, and telomere length was measured by Southern blot analysis on the mean length of terminal restriction fragment (TRF). RESULTS: Compared with the control group, a significant amount of telomere shortening was found in peripheral blood leukocytes from patients with schizophrenia who experienced poor response to antipsychotics (p < 0.001). CONCLUSION: Shortened telomere length in chronic schizophrenia may be a trait marker caused by oxidative stress, and the ensuing cellular dysfunction may be a factor contributing to the progressive deterioration in treatment-resistant schizophrenia.
OBJECTIVE: Telomere shortening has been observed in many human diseases, including atherosclerosis, cancer, aging syndromes, Alzheimer disease and vascular dementia. The present study aimed to investigate the mean telomere lengths of patients with schizophrenia. METHODS: We analyzed the lengths of telomeric DNA, comparing 2 groups of patients with schizophrenia (34 good responders and 34 poor responders). A control group of 76 healthy volunteers was also included. Blood samples were obtained, and telomere length was measured by Southern blot analysis on the mean length of terminal restriction fragment (TRF). RESULTS: Compared with the control group, a significant amount of telomere shortening was found in peripheral blood leukocytes from patients with schizophrenia who experienced poor response to antipsychotics (p < 0.001). CONCLUSION: Shortened telomere length in chronic schizophrenia may be a trait marker caused by oxidative stress, and the ensuing cellular dysfunction may be a factor contributing to the progressive deterioration in treatment-resistant schizophrenia.
Entities:
Keywords:
DNA restriction enzymes; blotting, Southern; schizophrenia; telomere
Authors: Anette Melk; Vido Ramassar; Lisa M H Helms; Ron Moore; David Rayner; Kim Solez; Philip F Halloran Journal: J Am Soc Nephrol Date: 2000-03 Impact factor: 10.121
Authors: T von Zglinicki; V Serra; M Lorenz; G Saretzki; R Lenzen-Grossimlighaus; R Gessner; A Risch; E Steinhagen-Thiessen Journal: Lab Invest Date: 2000-11 Impact factor: 5.662
Authors: H Aikata; H Takaishi; Y Kawakami; S Takahashi; M Kitamoto; T Nakanishi; Y Nakamura; F Shimamoto; G Kajiyama; T Ide Journal: Exp Cell Res Date: 2000-05-01 Impact factor: 3.905
Authors: Elissa S Epel; Elizabeth H Blackburn; Jue Lin; Firdaus S Dhabhar; Nancy E Adler; Jason D Morrow; Richard M Cawthon Journal: Proc Natl Acad Sci U S A Date: 2004-12-01 Impact factor: 11.205
Authors: Samuel J Ridout; Kathryn K Ridout; Hung-Teh Kao; Linda L Carpenter; Noah S Philip; Audrey R Tyrka; Lawrence H Price Journal: Adv Psychosom Med Date: 2015-03-30
Authors: Sabrina M Darrow; Josine E Verhoeven; Dóra Révész; Daniel Lindqvist; Brenda W J H Penninx; Kevin L Delucchi; Owen M Wolkowitz; Carol A Mathews Journal: Psychosom Med Date: 2016-09 Impact factor: 4.312
Authors: Daniel Lindqvist; Elissa S Epel; Synthia H Mellon; Brenda W Penninx; Dóra Révész; Josine E Verhoeven; Victor I Reus; Jue Lin; Laura Mahan; Christina M Hough; Rebecca Rosser; F Saverio Bersani; Elizabeth H Blackburn; Owen M Wolkowitz Journal: Neurosci Biobehav Rev Date: 2015-05-18 Impact factor: 8.989
Authors: Laura K M Han; Josine E Verhoeven; Audrey R Tyrka; Brenda W J H Penninx; Owen M Wolkowitz; Kristoffer N T Månsson; Daniel Lindqvist; Marco P Boks; Dóra Révész; Synthia H Mellon; Martin Picard Journal: Psychoneuroendocrinology Date: 2019-04-05 Impact factor: 4.905
Authors: Audrey R Tyrka; Stephanie H Parade; Lawrence H Price; Hung-Teh Kao; Barbara Porton; Noah S Philip; Emma S Welch; Linda L Carpenter Journal: Biol Psychiatry Date: 2015-01-15 Impact factor: 13.382
Authors: Laura Kananen; Ida Surakka; Sami Pirkola; Jaana Suvisaari; Jouko Lönnqvist; Leena Peltonen; Samuli Ripatti; Iiris Hovatta Journal: PLoS One Date: 2010-05-25 Impact factor: 3.240
Authors: Alessio Squassina; Mirko Manchia; Claudia Pisanu; Raffaella Ardau; Carlo Arzedi; Alberto Bocchetta; Paola Caria; Cristina Cocco; Donatella Congiu; Eleonora Cossu; Tinuccia Dettori; Daniela Virginia Frau; Mario Garzilli; Elias Manca; Anna Meloni; Maria Antonietta Montis; Andrea Mura; Mariella Nieddu; Barbara Noli; Pasquale Paribello; Federica Pinna; Renato Robledo; Giovanni Severino; Valeria Sogos; Maria Del Zompo; Gian Luca Ferri; Caterina Chillotti; Roberta Vanni; Bernardo Carpiniello Journal: Neuropsychopharmacology Date: 2020-09-12 Impact factor: 7.853